Correlation Between Brainsway and CTT Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brainsway and CTT Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brainsway and CTT Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brainsway and CTT Pharmaceutical Holdings, you can compare the effects of market volatilities on Brainsway and CTT Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brainsway with a short position of CTT Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brainsway and CTT Pharmaceutical.

Diversification Opportunities for Brainsway and CTT Pharmaceutical

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Brainsway and CTT is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Brainsway and CTT Pharmaceutical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTT Pharmaceutical and Brainsway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brainsway are associated (or correlated) with CTT Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTT Pharmaceutical has no effect on the direction of Brainsway i.e., Brainsway and CTT Pharmaceutical go up and down completely randomly.

Pair Corralation between Brainsway and CTT Pharmaceutical

Given the investment horizon of 90 days Brainsway is expected to under-perform the CTT Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Brainsway is 1.62 times less risky than CTT Pharmaceutical. The stock trades about 0.0 of its potential returns per unit of risk. The CTT Pharmaceutical Holdings is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  7.00  in CTT Pharmaceutical Holdings on September 1, 2024 and sell it today you would lose (0.01) from holding CTT Pharmaceutical Holdings or give up 0.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy91.3%
ValuesDaily Returns

Brainsway  vs.  CTT Pharmaceutical Holdings

 Performance 
       Timeline  
Brainsway 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Brainsway are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Brainsway showed solid returns over the last few months and may actually be approaching a breakup point.
CTT Pharmaceutical 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in CTT Pharmaceutical Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, CTT Pharmaceutical demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Brainsway and CTT Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brainsway and CTT Pharmaceutical

The main advantage of trading using opposite Brainsway and CTT Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brainsway position performs unexpectedly, CTT Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTT Pharmaceutical will offset losses from the drop in CTT Pharmaceutical's long position.
The idea behind Brainsway and CTT Pharmaceutical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation